NovoLog Mix 70/30 FlexPen and Trastuzumab and Hyaluronidase
Determining the interaction of NovoLog Mix 70/30 FlexPen and Trastuzumab and Hyaluronidase and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart / insulin aspart protamine
Brand name: NovoLog Mix 70/30, NovoLog Mix 70/30 FlexPen, NovoLOG Mix 70/30 PenFill
Synonyms: n.a.
Generic Name: hyaluronidase / trastuzumab
Brand name: Herceptin Hylecta
Synonyms: Hyaluronidase and trastuzumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- NovoLog Mix 70/30 FlexPen-Trastuzumab Injection (Intravenous)
- NovoLog Mix 70/30 FlexPen-Trastuzumab Intravenous
- NovoLog Mix 70/30 FlexPen-Trastuzumab-anns
- NovoLog Mix 70/30 FlexPen-Trastuzumab-dkst
- NovoLog Mix 70/30 FlexPen-Trastuzumab-dkst Intravenous
- NovoLog Mix 70/30 FlexPen-Trasylol
- Trastuzumab and Hyaluronidase-NovoLog PenFill
- Trastuzumab and Hyaluronidase-Novoseven
- Trastuzumab and Hyaluronidase-NovoSeven RT
- Trastuzumab and Hyaluronidase-NovoSeven RT with MixPro injection
- Trastuzumab and Hyaluronidase-Novothyrox
- Trastuzumab and Hyaluronidase-Noxafil